United States Biotechnology & Medical Research

Veracyte Inc (VCYT)

Track

Over the past 90 days, Veracyte Inc. insiders have engaged in 19 transactions, all of which were sales, totaling approximately $18.75 million in value. These transactions, primarily planned sales by executives including the CEO and CFO, occurred following a 76.8% stock price increase and a positive earnings report in May.
Ticker: VCYT Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Veracyte Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
EASTHAM KARIN
2 sales — total 197,234 USD
Planned sale 18 Jun 2026
Value US$4,656,262.74 | Price 252.98 | Shares 71,654
Planned sale 18 Jun 2026
Value US$4,043,638.69 | Price 222.06 | Shares 15,617
Proposed sale 18 Jun 2026
Value US$4,319,367.82 | Price 59.78 | Shares 71,025
Planned sale 4 Jun 2026
Value US$6,919,585.49 | Price 50.12 | Shares 138,051
Planned sale 4 Jun 2026
Value US$699,732.44 | Price 50.07 | Shares 13,975
Planned sale 4 Jun 2026
Value US$89,007.44 | Price 50.12 | Shares 1,776
Planned sale 4 Jun 2026
Value US$69,028.54 | Price 49.31 | Shares 1,400
Planned sale 4 Jun 2026
Value US$98,229.04 | Price 50.09 | Shares 1,961
Planned sale 4 Jun 2026
Value US$78,853.76 | Price 49.28 | Shares 1,600
Proposed sale 4 Jun 2026
Value US$154,639.44 | Price 48.69 | Shares 3,176
Proposed sale 4 Jun 2026
Value US$680,442.75 | Price 48.69 | Shares 13,975
Proposed sale 4 Jun 2026
Value US$6,721,703.19 | Price 48.69 | Shares 138,051
Proposed sale 4 Jun 2026
Value US$173,385.09 | Price 48.69 | Shares 3,561
Sale 22 May 2026
Value US$1,089,624.00 | Price 45.40 | Shares 24,000
Planned sale 20 May 2026
Value US$440,129.00 | Price 44.01 | Shares 10,000
Proposed sale 20 May 2026
Value US$416,900.00 | Price 41.69 | Shares 10,000
Planned sale 6 May 2026
Value US$204,080.00 | Price 40.00 | Shares 5,102
Planned sale 6 May 2026
Value US$194,131.10 | Price 38.05 | Shares 5,102
Proposed sale 6 May 2026
Value US$336,425.88 | Price 32.97 | Shares 10,204
Planned sale 4 Mar 2026
Value US$60,468.60 | Price 36.34 | Shares 1,664
Planned sale 4 Mar 2026
Value US$176,256.24 | Price 35.29 | Shares 4,994
Planned sale 4 Mar 2026
Value US$953,367.96 | Price 36.28 | Shares 26,279
Planned sale 4 Mar 2026
Value US$684,226.19 | Price 35.56 | Shares 19,244
Planned sale 4 Mar 2026
Value US$506,459.80 | Price 36.33 | Shares 13,941
Planned sale 4 Mar 2026
Value US$156,409.44 | Price 35.55 | Shares 4,400
Planned sale 4 Mar 2026
Value US$185,082.57 | Price 35.19 | Shares 5,260
Proposed sale 4 Mar 2026
Value US$184,520.80 | Price 35.08 | Shares 5,260
Proposed sale 4 Mar 2026
Value US$233,562.64 | Price 35.08 | Shares 6,658
Proposed sale 4 Mar 2026
Value US$643,402.28 | Price 35.08 | Shares 18,341
Proposed sale 4 Mar 2026
Value US$1,596,946.84 | Price 35.08 | Shares 45,523
Planned sale 2 Mar 2026
Value US$485,429.20 | Price 36.16 | Shares 13,425
Proposed sale 2 Mar 2026
Value US$491,220.75 | Price 36.59 | Shares 13,425
Planned sale 16 Dec 2025
Value US$4,368.00 | Price 43.68 | Shares 100
Planned sale 16 Dec 2025
Value US$458,835.60 | Price 43.13 | Shares 10,639
Proposed sale 16 Dec 2025
Value US$467,468.67 | Price 43.53 | Shares 10,739
Planned sale 5 Dec 2025
Value US$37,271.84 | Price 46.59 | Shares 800
Planned sale 5 Dec 2025
Value US$587,080.30 | Price 45.84 | Shares 12,808
Planned sale 5 Dec 2025
Value US$284,571.20 | Price 44.52 | Shares 6,392
Proposed sale 5 Dec 2025
Value US$948,200.00 | Price 47.41 | Shares 20,000
Proposed sale 4 Dec 2025
Value US$67,900.50 | Price 47.75 | Shares 1,422
Proposed sale 4 Dec 2025
Value US$634,024.50 | Price 47.75 | Shares 13,278
Proposed sale 4 Dec 2025
Value US$366,147.00 | Price 47.75 | Shares 7,668
Planned sale 4 Dec 2025
Value US$33,352.02 | Price 47.51 | Shares 702
Planned sale 4 Dec 2025
Value US$33,908.76 | Price 47.10 | Shares 720
Planned sale 4 Dec 2025
Value US$60,717.78 | Price 47.51 | Shares 1,278
Planned sale 4 Dec 2025
Value US$224,008.93 | Price 47.25 | Shares 4,741
Planned sale 4 Dec 2025
Value US$397,946.28 | Price 46.61 | Shares 8,537
Planned sale 4 Dec 2025
Value US$152,462.17 | Price 47.35 | Shares 3,220
Planned sale 4 Dec 2025
Value US$208,613.42 | Price 46.90 | Shares 4,448
Planned sale 25 Nov 2025
Value US$140,400.00 | Price 50.00 | Shares 2,808
Planned sale 25 Nov 2025
Value US$55,575.73 | Price 50.25 | Shares 1,106
Proposed sale 25 Nov 2025
Value US$246,900.00 | Price 49.38 | Shares 5,000
Proposed sale 25 Nov 2025
Value US$190,816.20 | Price 46.70 | Shares 4,086
Planned sale 20 Nov 2025
Value US$63,085.87 | Price 43.21 | Shares 1,460
Planned sale 20 Nov 2025
Value US$299,416.85 | Price 42.48 | Shares 7,049
Planned sale 20 Nov 2025
Value US$61,060.33 | Price 40.95 | Shares 1,491
Proposed sale 20 Nov 2025
Value US$423,562.80 | Price 42.36 | Shares 10,000
Sale 10 Nov 2025
Value US$215,978.37 | Price 42.33 | Shares 5,102
Sale 7 Nov 2025
Value US$233,928.98 | Price 40.21 | Shares 5,818
Planned sale 5 Nov 2025
Value US$387,191.21 | Price 40.02 | Shares 9,674
Planned sale 5 Nov 2025
Value US$30,468.77 | Price 46.38 | Shares 657
Planned sale 5 Nov 2025
Value US$1,110,990.48 | Price 45.73 | Shares 24,296
Planned sale 5 Nov 2025
Value US$264,640.47 | Price 45.07 | Shares 5,872
Planned sale 5 Nov 2025
Value US$474,701.78 | Price 43.80 | Shares 10,837
Planned sale 5 Nov 2025
Value US$48,455.05 | Price 43.03 | Shares 1,126
Planned sale 5 Nov 2025
Value US$17,031.18 | Price 41.74 | Shares 408
Planned sale 5 Nov 2025
Value US$287,000.00 | Price 41.00 | Shares 7,000
Planned sale 5 Nov 2025
Value US$258,640.00 | Price 40.00 | Shares 6,466
Proposed sale 5 Nov 2025
Value US$1,988,743.84 | Price 46.04 | Shares 43,196
Proposed sale 5 Nov 2025
Value US$349,424.88 | Price 36.12 | Shares 9,674
Proposed sale 5 Nov 2025
Value US$233,551.92 | Price 36.12 | Shares 6,466
Proposed sale 5 Nov 2025
Value US$252,840.00 | Price 36.12 | Shares 7,000
Planned sale 6 Oct 2025
Value US$300,709.27 | Price 36.02 | Shares 8,349
Proposed sale 6 Oct 2025
Value US$300,564.00 | Price 36.00 | Shares 8,349
Planned sale 1 Oct 2025
Value US$75,607.56 | Price 35.00 | Shares 2,160
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-22 2026-06-18 PlS Planned sale
EASTHAM KARIN
Non-Executive Director
71,654 -38.4%
252.98
US$4,656,263 		71,654 -38.4% 252.98 US$4,656,263
2026-06-22 2026-06-18 PlS Planned sale
EASTHAM KARIN
Non-Executive Director
15,617 +45.1%
222.06
US$4,043,639 		15,617 +45.1% 222.06 US$4,043,639
2026-06-18 2026-06-18 PrS Proposed sale
KARIN EASTHAM

Director

Non-Executive Director
71,025
59.78
US$4,319,368 		71,025 59.78 US$4,319,368
2026-06-04 2026-06-04 PlS Planned sale
2.6
Stapley Marc

Chief Executive Officer

Executive Director
138,051 -23.9%
50.12
US$6,919,585 		138,051 -23.9% 50.12 US$6,919,585
2026-06-04 2026-06-04 PlS Planned sale
3.2
Leite John

Global Chief Commercial Off

Officer
13,975 -9.6%
50.07
US$699,732 		13,975 -9.6% 50.07 US$699,732
2026-06-04 2026-06-04 PlS Planned sale
McGuire Annie

EVP, General Counsel

Officer
1,776 -1.3%
50.12
US$89,007 		1,776 -1.3% 50.12 US$89,007
2026-06-04 2026-06-04 PlS Planned sale
McGuire Annie

EVP, General Counsel

Officer
1,400 -1.0%
49.31
US$69,029 		1,400 -1.0% 49.31 US$69,029
2026-06-04 2026-06-04 PlS Planned sale
0.7
Chambers Rebecca

Chief Financial Officer

Officer
1,961 -1.1%
50.09
US$98,229 		1,961 -1.1% 50.09 US$98,229
2026-06-04 2026-06-04 PlS Planned sale
0.7
Chambers Rebecca

Chief Financial Officer

Officer
1,600 -0.9%
49.28
US$78,854 		1,600 -0.9% 49.28 US$78,854
2026-06-04 2026-06-04 PrS Proposed sale
ANN MCGUIRE

Officer

Officer
3,176
48.69
US$154,639 		3,176 48.69 US$154,639
2026-06-04 2026-06-04 PrS Proposed sale
3.2
John Leite

Officer

Officer
13,975
48.69
US$680,443 		13,975 48.69 US$680,443
2026-06-04 2026-06-04 PrS Proposed sale
2.6
MARC STAPLEY

Director; Officer

Executive Director
138,051
48.69
US$6,721,703 		138,051 48.69 US$6,721,703
2026-06-04 2026-06-04 PrS Proposed sale
0.7
REBECCA CHAMBERS

Officer

Officer
3,561
48.69
US$173,385 		3,561 48.69 US$173,385
2026-05-27 2026-05-22 S Sale
3.1
Wygant Jonathan

VP, Chief Accounting Officer

Officer
24,000 -34.6%
45.40
US$1,089,624 		24,000 -34.6% 45.40 US$1,089,624
2026-05-22 2026-05-20 PlS Planned sale
EPSTEIN ROBERT S
Non-Executive Director
10,000 -16.0%
44.01
US$440,129 		10,000 -16.0% 44.01 US$440,129
2026-05-20 2026-05-20 PrS Proposed sale
ROBERT EPSTEIN

Director

Non-Executive Director
10,000
41.69
US$416,900 		10,000 41.69 US$416,900
2026-05-08 2026-05-06 PlS Planned sale
McGuire Annie

SVP, General Counsel

Officer
5,102 -3.4%
40.00
US$204,080 		5,102 -3.4% 40.00 US$204,080
2026-05-08 2026-05-06 PlS Planned sale
McGuire Annie

SVP, General Counsel

Officer
5,102 -3.3%
38.05
US$194,131 		5,102 -3.3% 38.05 US$194,131
2026-05-06 2026-05-06 PrS Proposed sale
ANN MCGUIRE

Officer

Officer
10,204
32.97
US$336,426 		10,204 32.97 US$336,426
2026-03-06 2026-03-04 PlS Planned sale
McGuire Annie

SVP, General Counsel

Officer
1,664 -1.7%
36.34
US$60,469 		1,664 -1.7% 36.34 US$60,469
2026-03-06 2026-03-04 PlS Planned sale
McGuire Annie

SVP, General Counsel

Officer
4,994 -4.9%
35.29
US$176,256 		4,994 -4.9% 35.29 US$176,256
2026-03-06 2026-03-04 PlS Planned sale
2.6
Stapley Marc

Chief Executive Officer

Executive Director
26,279 -6.8%
36.28
US$953,368 		26,279 -6.8% 36.28 US$953,368
2026-03-06 2026-03-04 PlS Planned sale
2.6
Stapley Marc

Chief Executive Officer

Executive Director
19,244 -4.8%
35.56
US$684,226 		19,244 -4.8% 35.56 US$684,226
2026-03-06 2026-03-04 PlS Planned sale
0.7
Chambers Rebecca

Chief Financial Officer

Officer
13,941 -9.6%
36.33
US$506,460 		13,941 -9.6% 36.33 US$506,460
2026-03-06 2026-03-04 PlS Planned sale
0.7
Chambers Rebecca

Chief Financial Officer

Officer
4,400 -2.9%
35.55
US$156,409 		4,400 -2.9% 35.55 US$156,409
2026-03-06 2026-03-04 PlS Planned sale
3.2
Leite John

Chief Commercial Officer-CLIA

Officer
5,260 -4.7%
35.19
US$185,083 		5,260 -4.7% 35.19 US$185,083
2026-03-04 2026-03-04 PrS Proposed sale
3.2
John Leite

Officer

Officer
5,260
35.08
US$184,521 		5,260 35.08 US$184,521
2026-03-04 2026-03-04 PrS Proposed sale
ANN MCGUIRE

Officer

Officer
6,658
35.08
US$233,563 		6,658 35.08 US$233,563
2026-03-04 2026-03-04 PrS Proposed sale
0.7
REBECCA CHAMBERS

Officer

Officer
18,341
35.08
US$643,402 		18,341 35.08 US$643,402
2026-03-04 2026-03-04 PrS Proposed sale
2.6
MARC STAPLEY

Director; Officer

Executive Director
45,523
35.08
US$1,596,947 		45,523 35.08 US$1,596,947
2026-03-04 2026-03-02 PlS Planned sale
Febbo Phillip G.

Chief Scientific & Med Officer

Officer
13,425 -10.3%
36.16
US$485,429 		13,425 -10.3% 36.16 US$485,429
2026-03-02 2026-03-02 PrS Proposed sale
PHILLIP FEBBO

Officer

Officer
13,425
36.59
US$491,221 		13,425 36.59 US$491,221
2025-12-17 2025-12-16 PlS Planned sale
McGuire Annie

SVP, General Counsel

Officer
100 -0.1%
43.68
US$4,368 		100 -0.1% 43.68 US$4,368
2025-12-17 2025-12-16 PlS Planned sale
McGuire Annie

SVP, General Counsel

Officer
10,639 -13.6%
43.13
US$458,836 		10,639 -13.6% 43.13 US$458,836
2025-12-16 2025-12-16 PrS Proposed sale
ANN MCGUIRE

Officer

Officer
10,739
43.53
US$467,469 		10,739 43.53 US$467,469
2025-12-08 2025-12-05 PlS Planned sale
EASTHAM KARIN
Non-Executive Director
800 -5.6%
46.59
US$37,272 		800 -5.6% 46.59 US$37,272
2025-12-08 2025-12-05 PlS Planned sale
EASTHAM KARIN
Non-Executive Director
12,808 -47.2%
45.84
US$587,080 		12,808 -47.2% 45.84 US$587,080
2025-12-08 2025-12-05 PlS Planned sale
EASTHAM KARIN
Non-Executive Director
6,392 -19.0%
44.52
US$284,571 		6,392 -19.0% 44.52 US$284,571
2025-12-05 2025-12-05 PrS Proposed sale
KARIN EASTHAM

Director

Non-Executive Director
20,000
47.41
US$948,200 		20,000 47.41 US$948,200
2025-12-04 2025-12-04 PrS Proposed sale
ANN MCGUIRE

Officer

Officer
1,422
47.75
US$67,900 		1,422 47.75 US$67,900
2025-12-04 2025-12-04 PrS Proposed sale
0.7
REBECCA CHAMBERS

Officer

Officer
13,278
47.75
US$634,024 		13,278 47.75 US$634,024
2025-12-04 2025-12-04 PrS Proposed sale
2.6
MARC STAPLEY

Director; Officer

Executive Director
7,668
47.75
US$366,147 		7,668 47.75 US$366,147
2025-12-04 2025-12-04 PlS Planned sale
McGuire Annie

SVP, General Counsel

Officer
702 -0.9%
47.51
US$33,352 		702 -0.9% 47.51 US$33,352
2025-12-04 2025-12-04 PlS Planned sale
McGuire Annie

SVP, General Counsel

Officer
720 -0.9%
47.10
US$33,909 		720 -0.9% 47.10 US$33,909
2025-12-04 2025-12-04 PlS Planned sale
3.2
Leite John

Chief Commercial Officer-CLIA

Officer
1,278 -1.5%
47.51
US$60,718 		1,278 -1.5% 47.51 US$60,718
2025-12-04 2025-12-04 PlS Planned sale
0.7
Chambers Rebecca

Chief Financial Officer

Officer
4,741 -4.2%
47.25
US$224,009 		4,741 -4.2% 47.25 US$224,009
2025-12-04 2025-12-04 PlS Planned sale
0.7
Chambers Rebecca

Chief Financial Officer

Officer
8,537 -7.0%
46.61
US$397,946 		8,537 -7.0% 46.61 US$397,946
2025-12-04 2025-12-04 PlS Planned sale
2.6
Stapley Marc

Chief Executive Officer

Executive Director
3,220 -1.0%
47.35
US$152,462 		3,220 -1.0% 47.35 US$152,462
2025-12-04 2025-12-04 PlS Planned sale
2.6
Stapley Marc

Chief Executive Officer

Executive Director
4,448 -1.4%
46.90
US$208,613 		4,448 -1.4% 46.90 US$208,613
2025-11-26 2025-11-25 PlS Planned sale
3.2
Leite John

Chief Commercial Officer-CLIA

Officer
2,808 -3.2%
50.00
US$140,400 		2,808 -3.2% 50.00 US$140,400
2025-11-26 2025-11-25 PlS Planned sale
1.6
JONES EVAN/ FA
Non-Executive Director
1,106 -3.6%
50.25
US$55,576 		1,106 -3.6% 50.25 US$55,576
2025-11-25 2025-11-25 PrS Proposed sale
1.6
Evan Jones

Director

Non-Executive Director
5,000
49.38
US$246,900 		5,000 49.38 US$246,900
2025-11-25 2025-11-25 PrS Proposed sale
3.2
John Leite

Officer

Officer
4,086
46.70
US$190,816 		4,086 46.70 US$190,816
2025-11-21 2025-11-20 PlS Planned sale
1.5
Holstein Jens
Non-Executive Director
1,460 -5.1%
43.21
US$63,086 		1,460 -5.1% 43.21 US$63,086
2025-11-21 2025-11-20 PlS Planned sale
1.5
Holstein Jens
Non-Executive Director
7,049 -19.7%
42.48
US$299,417 		7,049 -19.7% 42.48 US$299,417
2025-11-21 2025-11-20 PlS Planned sale
1.5
Holstein Jens
Non-Executive Director
1,491 -4.0%
40.95
US$61,060 		1,491 -4.0% 40.95 US$61,060
2025-11-20 2025-11-20 PrS Proposed sale
1.5
JENS HOLSTEIN

Director

Non-Executive Director
10,000
42.36
US$423,563 		10,000 42.36 US$423,563
2025-11-12 2025-11-10 S Sale
3.1
Wygant Jonathan

VP, Chief Accounting Officer

Officer
5,102 -11.6%
42.33
US$215,978 		5,102 -11.6% 42.33 US$215,978
2025-11-12 2025-11-07 S Sale
3.1
Wygant Jonathan

VP, Chief Accounting Officer

Officer
5,818 -11.7%
40.21
US$233,929 		5,818 -11.7% 40.21 US$233,929
2025-11-07 2025-11-05 PlS Planned sale
EASTHAM KARIN
Non-Executive Director
9,674 -41.6%
40.02
US$387,191 		9,674 -41.6% 40.02 US$387,191
2025-11-07 2025-11-05 PlS Planned sale
1.6
JONES EVAN/ FA
Non-Executive Director
657 -2.1%
46.38
US$30,469 		657 -2.1% 46.38 US$30,469
2025-11-07 2025-11-05 PlS Planned sale
1.6
JONES EVAN/ FA
Non-Executive Director
24,296 -43.8%
45.73
US$1,110,990 		24,296 -43.8% 45.73 US$1,110,990
2025-11-07 2025-11-05 PlS Planned sale
1.6
JONES EVAN/ FA
Non-Executive Director
5,872 -9.6%
45.07
US$264,640 		5,872 -9.6% 45.07 US$264,640
2025-11-07 2025-11-05 PlS Planned sale
1.6
JONES EVAN/ FA
Non-Executive Director
10,837 -15.0%
43.80
US$474,702 		10,837 -15.0% 43.80 US$474,702
2025-11-07 2025-11-05 PlS Planned sale
1.6
JONES EVAN/ FA
Non-Executive Director
1,126 -1.5%
43.03
US$48,455 		1,126 -1.5% 43.03 US$48,455
2025-11-07 2025-11-05 PlS Planned sale
1.6
JONES EVAN/ FA
Non-Executive Director
408 -0.6%
41.74
US$17,031 		408 -0.6% 41.74 US$17,031
2025-11-07 2025-11-05 PlS Planned sale
0.7
Chambers Rebecca

Chief Financial Officer

Officer
7,000 -5.3%
41.00
US$287,000 		7,000 -5.3% 41.00 US$287,000
2025-11-07 2025-11-05 PlS Planned sale
McGuire Annie

SVP, General Counsel

Officer
6,466 -7.2%
40.00
US$258,640 		6,466 -7.2% 40.00 US$258,640
2025-11-05 2025-11-05 PrS Proposed sale
1.6
Evan Jones

Director

Non-Executive Director
43,196
46.04
US$1,988,744 		43,196 46.04 US$1,988,744
2025-11-05 2025-11-05 PrS Proposed sale
KARIN EASTHAM

Director

Non-Executive Director
9,674
36.12
US$349,425 		9,674 36.12 US$349,425
2025-11-05 2025-11-05 PrS Proposed sale
ANN MCGUIRE

Officer

Officer
6,466
36.12
US$233,552 		6,466 36.12 US$233,552
2025-11-05 2025-11-05 PrS Proposed sale
0.7
REBECCA CHAMBERS

Officer

Officer
7,000
36.12
US$252,840 		7,000 36.12 US$252,840
2025-10-07 2025-10-06 PlS Planned sale
Febbo Phillip G.

Chief Scientific & Med Officer

Officer
8,349 -8.3%
36.02
US$300,709 		8,349 -8.3% 36.02 US$300,709
2025-10-06 2025-10-06 PrS Proposed sale
PHILLIP FEBBO

Officer

Officer
8,349
36.00
US$300,564 		8,349 36.00 US$300,564
2025-10-03 2025-10-01 PlS Planned sale
McGuire Annie

SVP, General Counsel

Officer
2,160 -2.4%
35.00
US$75,608 		2,160 -2.4% 35.00 US$75,608
Explore more

More insider trading research around Veracyte Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America